Search results

Help

Butterworth IV, John F.; Mackey, David C.; Wasnick, John D. (2022), "Neuromuscular Blocking Agents", Morgan & Mikhail’s Clinical Anesthesiology (7 ed.), New

clinical practice Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia

Cisatracurium is a benzylisoquinolinium intermediate acting nondepolarizing neuromuscular blocking agent used for tracheal intubation and surgical relaxation

in the United States of America Goodwin, G., Joseph, V. (2015). Neuromuscular Blockers. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology

sensitive to nondepolarizing neuromuscular blockers Resistant to succinylcholine At increased risk for developing phase II neuromuscular block, particularly

midazolam, ketamine, or dexmedetomidine with a longer acting nondepolarizing neuromuscular blocker infusion. Tend to avoid propofol due to risk of interfering

Used to revere the effects of neuromuscular blocking agents. Neostigmine reverses the effects of neuromuscular blocking agents by inhibiting acetylcholinesterase

(primarily class 1A and 1C antiarrhythmics) Sugammadex should be used for neuromuscular blockade reversal Manage arrhythmic storm with defibrillation, isoprotenerol